CREATING THERAPEUTIC ABUNDANCE

Summary from the TLDR newsletter

The invention of new medicines is limited by our knowledge of cells and molecules that can be manipulated to treat disease. The cost of discovering new medicines is increasing. New technologies have the potential to unlock an era of target abundance and reverse the long decline in research and development productivity. This could be one of AI's most important impacts.